Shield Therapeutics plc
STX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£21 | -£33 | -£29 | -£20 |
| Dep. & Amort. | £1 | £1 | £2 | £2 |
| Deferred Tax | £0 | £0 | £0 | £2 |
| Stock-Based Comp. | £0 | £1 | £1 | £1 |
| Change in WC | £13 | -£7 | £3 | -£2 |
| Other Non-Cash | £1 | £1 | £4 | -£1 |
| Operating Cash Flow | -£7 | -£37 | -£18 | -£17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£2 | -£0 | -£2 | -£2 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | -£2 | £0 | £0 |
| Investing Cash Flow | -£2 | -£2 | -£2 | -£2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £4 | £24 | £9 | £0 |
| Stock Issued | -£0 | £27 | £0 | £37 |
| Stock Repurch. | £0 | £0 | -£0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£0 | -£1 | -£1 | -£10 |
| Financing Cash Flow | £4 | £50 | £8 | £28 |
| Forex Effect | -£1 | £0 | £3 | £0 |
| Net Chg. in Cash | -£5 | £11 | -£9 | £9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £11 | £3 | £12 | £3 |
| End Cash | £6 | £14 | £3 | £12 |
| Free Cash Flow | -£7 | -£40 | -£20 | -£19 |